Aspirin and salicylate induce apoptosis and activation of caspases in B- cell chronic lymphocytic leukemia cells

Blood

Volumn 92, Issue 4, 1998, Pages 1406-1414

  Bellosillo, Beatriz ^b   Piqué, Maria ^b   Barragán, Montserrat ^b   Castaño, Esther ^b   Villamor, Neus ^b   Colomer, Dolors ^b   Montserrat, Emilio ^b   Pons, Gabriel ^b   Gil, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; SALICYLIC ACID;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0032529499     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1406.416k17_1406_1414     Document Type: Article

References (61)

1. Foon KA, Rai KR. Gale RP: Chronic lymphocytic leukemia: New insights into biology and therapy. Ann Intern Med 113:525, 1990
2. Rozman C, Montserrat E: Chronic lymphocytic leukemia. N Engl J Med 333:1052, 1995
3. Gale RP, Caligaris-Cappio F, Dighiero G, Keating M, Montserrat E, Rai K: Recent progress in chronic lymphocytic leukemia. Leukemia 8:1610, 1994
4. Krammer PH, Behrmann I, Daniel R Dhein J, Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 6:279, 1994
5. Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845, 1997
6. McConkey DJ, Aguilar-Santelises M, Hartzell P, Eriksson I, Mellstedt H, Orrenius S, Jondal M: Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol 146:1072, 1991
7. Carrera CJ, Piro LD, Saven A, Beutler E, Terai C, Carson DA: 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes. Adv Exp Med Biol 309A:15, 1991
8. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W: Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood 81:143, 1993
9. Begleiter A, Lee K, Israels LG, Mowat MRA, Johnston JB: Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Leukemia 8:S103, 1994 (suppl 1)
10. Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M, Newcomb EW: Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance, Oncogene 12:1055, 1996
11. Bellosillo B, Colomer D, Pons G. Gil J: Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol 100:142, 1998
12. Henkart PA: ICE family of proteases: Mediators of all apoptotic cell death? Immunity 4:195, 1996
13. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
14. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
15. Bellosillo B, Dalmau M, Colomer D, Gil J: Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood 89:3378, 1997
16. Lu X, Xie W, Reed D, Bradshaw WS, Simmons DL: Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci USA 92:7961, 1995
17. Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, Ahnen DJ: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55:3110, 1995
18. Shiff SJ, Qiao L, Tsai LL, Rigas B: Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96:491, 1995
19. Elder DJE, Hague A, Hicks DJ, Paraskeva C: Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res 56:2273, 1996
20. Shiff SJ, Koutsos MI, Qiao L, Rigas B: Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis. Exp Cell Res 222:179, 1996
21. Vane JR: Inhibition of prostaglandin synthesis as mechanism of action for aspirin-like drugs. Nat New Biol 231:232, 1971
22. Smith WL: The eicosanoids and their biochemical mechanism of action. Biochem J 259:315, 1989
23. Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H syntases (cyclooxygenases)-1 and -2. J Biol Chem 271:33157, 1996
24. Tsujii M, Dubois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83:493, 1995
25. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B: Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52:237, 1996
26. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198, 1981
27. Carballo E, Colomer D, Vives Corrons JL, Blackshear PJ, Gil J: Characterization and purification of a protein kinase C substrate in human B cells. J Immunol 156:1709, 1996
28. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
30. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
31. Koopman G, Reutelingsperger CP, Kuijten GA, Rechnen RM, Pals ST, van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
32. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K: Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 305:479, 1995
33. Barnett J, Chow J, Tves D, Chiou M, Mackenzie R, Osen E, Nguyen B. Tsing S, Bach C, Freire J, Chan H, Sigal E, Ramesha C: Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta 1209:130, 1994
34. Chulada PC, Langenbach R: Differential inhibition of murine prostaglandin synthase-1 and -2 by non-steroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid. J Pharmacol Exp Ther 280:606, 1997
35. Kargman S, Wong E, Greig GM, Falgueyret JP, Cromlish W, Ethier D, Yergey JA, Riendeau D, Evans JF, Kennedy B, Tagari P, Francis DA, O'Neill GP: Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells. Biochem Pharmacol 52:1113, 1996
36. Miralpeix M, Camacho M, Lopez-Belmonte J, Canalias F, Beleta J, Palacios JM, Vila L: Selective induction of cyclo-oxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: Biochemical and pharmacological characterization. Br J Pharmacol 121:171, 1997
37. Qiao L, Hanif R, Sphicas E, Sniff SJ, Rigas B: Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem Pharmacol 55:53, 1998
38. Thompson HJ, Briggs S, Paranka NS, Piazza GA, Brendel K, Gross PH, Sperl GH, Pamukcu R, Ahnen DJ: Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J Natl Cancer Inst 87:1259, 1995
39. Castano E, Dalmau M, Marti M, Berrocal F, Battrons R, Gil J: Inhibition of DNA synthesis by aspirin in Swiss 3T3 fibroblasts. J Pharmacol Exp Ther 280:366, 1997
40. Kopp E, Ghosh S: Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956, 1994
41. Weber C, Erl W, Pietsch A, Weber PC: Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91:1914, 1995
42. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T: Salicylates inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression and neutrophil transmigration. J Immunol 156:3961, 1996
43. Grilli M, Pizzi M, Memo M, Spano P: Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274:1383, 1996
44. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, Fitzgerald MJ, Rothstein TL, Sherr DH, Sonenshein GE: Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 15:4682, 1996
45. Arsura M, Wu M, Sonenshein GE: TGFβ-1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IκBα. Immunity 5:31, 1996
46. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782, 1996
47. Wang CY, Mayo MW, Baldwin AS: TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784, 1996
48. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787, 1996
49. Liu ZG, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565, 1996
50. Dong Z, Huang C, Brown RE, Ma WY: Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 272:9962, 1997
51. Schwenger P, Bellosta P, Victor I, Basilico C, Skolnik EY, Vilcek J: Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94:2869, 1997
52. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA: Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mlgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci USA 93:13814, 1996
53. Higgs GA, Salmon JA, Henderson B, Vane JR: Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinfiammatory activity. Proc Natl Acad Sci USA 84:1417, 1987
54. Insel PA: Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout, in Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York, NY, McGrawHill, 1996, p 617
55. USP Dispending Information - Vol I. Drug Information for the Health Care Professional. The United States Pharmacopeial Convention, Inc. Taunton, MA, Rand McNally, 1996, p 2592
56. Hart FD, Huskisson EC: Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use. Drugs 27:232, 1984
57. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S: A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355, 1991
58. Thun MJ, Namboodiri MM, Heath CW: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593, 1991
59. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med 333:609, 1995
60. Weiss HA, Forman D: Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: A review of the epidemiological evidence. Scand J Gastroenterol 31:137, 1996 (suppl 220)
61. Rosenberg L: Nonsteroidal anti-inflammatory drugs and cancer. Prev Med 24:107, 1995